The nitroxyl anion (HNO) is a potent dilator of rat coronary vasculature
- PMID: 17189622
- DOI: 10.1016/j.cardiores.2006.11.018
The nitroxyl anion (HNO) is a potent dilator of rat coronary vasculature
Abstract
Objective: The nitroxyl anion (HNO) is the one-electron reduction product of NO(). This redox variant has been shown to be endogenously produced and to have effects that are pharmacologically distinct from NO(). This study investigates the vasodilator and chronotropic effects of HNO in the rat isolated coronary vasculature.
Methods: Sprague-Dawley rat hearts were retrogradely perfused with Krebs' solution (8 ml/min) using the Langendorff technique. Perfusion pressure was raised using a combination of infusion of phenylephrine and bolus additions of the thromboxane mimetic U46619 to attain a baseline perfusion pressure of 100-120 mm Hg. The vasodilator effects of a nitroxyl anion donor, Angeli's salt, were examined in the absence and presence of HNO and NO* scavengers, K+ channel inhibition, and soluble guanylate cyclase (sGC) inhibition. In addition, the inotropic and chronotropic effects of Angeli's salt were examined in hearts at resting perfusion pressure (50-60 mm Hg) and compared to responses evoked by acetylcholine and isoprenaline.
Results: Angeli's salt causes a potent and reproducible vasodilatation in isolated perfused rat hearts. This response is unaffected by the NO* scavenger hydroxocobalamin (0.1 mM) but is significantly inhibited by the HNO scavenger N-acetyl-L-cysteine (4 mM), suggesting that HNO is the mediator of the observed responses. Vasodilatation responses to Angeli's salt were virtually abolished in the presence of the sGC inhibitor ODQ (10 microM). The magnitude of the vasodilatation response to Angeli's salt was significantly reduced in the presence of 30 mM K+, 10 microM glibenclamide and in the presence of the calcitonin gene-related peptide (CGRP) antagonist CGRP((8-37)) (0.1 microM). Angeli's salt had little effect on heart rate or force of contraction, whilst isoprenaline and acetylcholine elicited significant positive and negative cardiotropic effects, respectively.
Conclusions: The HNO donor Angeli's salt elicits a potent and reproducible vasodilatation response. The results suggest that the response is elicited by HNO through sGC-mediated CGRP release and K(ATP) channel activation.
Similar articles
-
The concomitant coronary vasodilator and positive inotropic actions of the nitroxyl donor Angeli's salt in the intact rat heart: contribution of soluble guanylyl cyclase-dependent and -independent mechanisms.Br J Pharmacol. 2014 Apr;171(7):1722-34. doi: 10.1111/bph.12568. Br J Pharmacol. 2014. PMID: 24372173 Free PMC article.
-
Redox variants of NO (NO{middle dot} and HNO) elicit vasorelaxation of resistance arteries via distinct mechanisms.Am J Physiol Heart Circ Physiol. 2009 May;296(5):H1274-80. doi: 10.1152/ajpheart.00008.2009. Epub 2009 Feb 27. Am J Physiol Heart Circ Physiol. 2009. PMID: 19252101
-
NO- activates soluble guanylate cyclase and Kv channels to vasodilate resistance arteries.Hypertension. 2003 Jun;41(6):1301-7. doi: 10.1161/01.HYP.0000072010.54901.DE. Epub 2003 May 12. Hypertension. 2003. PMID: 12743008
-
Nitroxyl (HNO) as a vasoprotective signaling molecule.Antioxid Redox Signal. 2011 May 1;14(9):1675-86. doi: 10.1089/ars.2010.3327. Epub 2010 Nov 2. Antioxid Redox Signal. 2011. PMID: 20673125 Review.
-
The chemistry of nitroxyl-releasing compounds.Antioxid Redox Signal. 2011 May 1;14(9):1637-48. doi: 10.1089/ars.2010.3838. Epub 2011 Mar 2. Antioxid Redox Signal. 2011. PMID: 21235345 Free PMC article. Review.
Cited by
-
Therapeutic Potential of Nitroxyl (HNO) Donors in the Management of Acute Decompensated Heart Failure.Drugs. 2016 Sep;76(14):1337-48. doi: 10.1007/s40265-016-0631-y. Drugs. 2016. PMID: 27566478 Review.
-
H2S and NO cooperatively regulate vascular tone by activating a neuroendocrine HNO-TRPA1-CGRP signalling pathway.Nat Commun. 2014 Jul 15;5:4381. doi: 10.1038/ncomms5381. Nat Commun. 2014. PMID: 25023795 Free PMC article.
-
The alpha1 isoform of soluble guanylate cyclase regulates cardiac contractility but is not required for ischemic preconditioning.Basic Res Cardiol. 2011 Jun;106(4):635-43. doi: 10.1007/s00395-011-0167-y. Epub 2011 Mar 11. Basic Res Cardiol. 2011. PMID: 21394564 Free PMC article.
-
Nitroxyl inhibits overt pain-like behavior in mice: role of cGMP/PKG/ATP-sensitive potassium channel signaling pathway.Pharmacol Rep. 2014 Aug;66(4):691-8. doi: 10.1016/j.pharep.2014.04.003. Epub 2014 Apr 22. Pharmacol Rep. 2014. PMID: 24948073 Free PMC article.
-
The Anti-fibrotic Actions of Relaxin Are Mediated Through a NO-sGC-cGMP-Dependent Pathway in Renal Myofibroblasts In Vitro and Enhanced by the NO Donor, Diethylamine NONOate.Front Pharmacol. 2016 Mar 31;7:91. doi: 10.3389/fphar.2016.00091. eCollection 2016. Front Pharmacol. 2016. PMID: 27065874 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials